Cardiovascular Devices Market

Cardiovascular Devices Market Size

The global cardiovascular devices market size was estimated at USD 7.5 billion in 2024. The market is expected to grow from 8.4 billion in 2025 to 26.3 billion in 2034, at a CAGR of 13.5%. Cardiovascular devices are designed to monitor, diagnose, or to treat the medical conditions associated with the heart as well as the circulatory system. These include various medical devices such as diagnostic cardiovascular devices such as the electrocardiographs, therapeutic devices such as stents, which is estimated to reach USD USD 12 billion by 2032, and pacemaker, among others.

The growth of the global market is primarily attributed to the rising prevalence of the cardiovascular diseases. For instance, as per the data from the World Health Organization (WHO), every year around 17.9 million deaths are reported due to cardiovascular diseases globally. Furthermore, according to the U.S. Centers for Disease Control and Prevention (CDC), heart disease is the major cause of the death among the individuals in the U.S. In 2022, around 702,880 individuals in the U.S. had lost their lives due to heart disease, which is equivalent to 1 in 5 deaths in the U.S.

Therefore, the rising cases of cardiovascular diseases and associated deaths is accelerating the need for innovative cardiovascular devices such as stents, pacemakers, cardiac monitors, among others in order to manage the condition associated with heart such as heart failure, arrhythmias, and coronary artery disease.

Furthermore, in recent times, there is a massive traction of the patients and healthcare providers towards the minimal invasive procedures due to the benefits offered by these procedures which includes, shorter hospital stays and recovery time, lower risk, and minimal scaring. In the field of cardiology, minimal invasive procedures such as catheter-based ablation technique, percutaneous coronary interventions, among others have transformed the treatment landscape.

Thus, the healthcare givers and patients are inclining towards these procedures as compared to the traditional open-heart surgery, stimulating the demand for advanced cardiovascular devices such as cryoablation catheters, left atrial appendage closure devices, and many more.

Cardiovascular Devices Market Trends

• The aging population is one of the key catalyst for the growth of the market. Individuals from this demographic are more prone to develop a heart disease, due to the age associated physiological changes including decreased cardiac function, and arterial stiffening.
  
• For instance, the World Health Organization (WHO) projected that by 2030 the population of individuals belonging to the age group 60 will reach 1.4 billion from 1 billion in 2020, further the population of this age group will reach 2.1 billion by 2050. Moreover, by 2050 two third of this population will be part of middle- and low-income countries.
  
• Thus, this rising aging population stimulate the need for the advanced cardiovascular devices in order to address the age-related heart condition, thereby driving the market growth.
  
• Furthermore, technological innovations, such as the development of wearable cardiac devices and smart medical devices integrated with the AI for monitoring the patient’s conditions in real time, further cementing the adoption of the cardiac devices among the healthcare provider and patient, which in turn is stimulating the growth and the demand of the advanced cardiovascular devices in the market.
  

Cardiovascular Devices Market Analysis

Based on device type, the market is segmented into cardiac ablation devices, left atrial appendage closure devices, and endoscopic vessel harvesting devices.  The market was estimated at USD 7.5 billion in 2024. The cardiac ablation devices segment held revenue of USD 5.1 billion in 2024 and the segment is poised for significant growth at a CAGR of 13.7% during the forecast period.

• The growth of this segment is highly attributed to the increasing prevalence of atrial fibrillation which is one of the most common arrhythmias across the globe.
  
• For instance, according to 2024 study published in the Lancet journal, the number of individuals affected by atrial fibrillation as increased from 33.5 million in 2010 to 59 million in 2019. Moreover, as per the data from the Centers for Disease Control and Prevention (CDC), each year in the U.S. nearly 454,000 hospitalization and 158,000 deaths occur due to atrial fibrillation.
  
• The cardiac ablation devices offer a minimally invasive approach to in order to restore the normal heart rhythm among the patients affected form atrial fibrillation, thus propelling the demand of cardiac ablation device.
• Moreover, the rising awareness regarding the early diagnosis and risk associated with the untreated atrial fibrillation further supporting the segment growth.
  
• For instance, as the per the 2023 study published in National Center for Biotechnology information, ablation is the first line therapy for the treatment of patients diagnosed with atrial fibrillation, this therapy decrease the chance of recurrence of the diseases.
  
• Therefore, as the rate of diagnosis increase so does the need for advanced cardiac ablation devices, stemming the growth of the segment.
  

Based on end use, the cardiovascular devices market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and other end users. The hospitals segment accounted for USD 4.4 billion with a revenue share of 58.3% in 2024.

• Hospitals encounter a greater number of patients undergoing complex cardiac procedures which include catheterizations, bypass surgeries, and devices implantation.
  
• Hospitals capability to address larger volume of cardiac patients in both emergency as well as in patient department making them a key contributor for the number of cardiovascular procedures performed, thereby propelling the market growth.
  
• Moreover, hospital encompass large number of skilled professionals such as cardiologist and the supporting staff under the cardiology department of the hospitals, making them a preferred choice among the patients undergoing both emergency and elective cardiology procedures.
  
• Furthermore, these facilities are well equipped with high end cardiovascular devices and laboratories such as the Cath labs, hybrid operation theaters, among others intended for a cardiovascular producer, thereby boosting the segmental growth.
  

The U.S. cardiovascular devices market accounted for USD 2.5 billion in 2023 and is forecasted to reach USD 9.7 billion by 2034.

• The availability of high skilled cardiovascular professionals with specialization in cardiac surgery, interventional cardiologist, and electrophysiologists significantly contributing to the market growth in the country.
  
• For instance, in 2023, the American Heart Association reported around 9,594 interventional cardiologist, 47,225 cardiologist, and 4,328 electrophysiologists in the U.S.
  
• Moreover, the technological advancements and adoption of the advanced cardiovascular devices across the country further fueling the growth of the market in the country.
  

Europe: The UK is set to see a robust expansion in its cardiovascular devices market from 2025 to 2034.

• The country’s well established healthcare system and the rising demand for advanced cardiovascular procedures are the key factors stimulating the growth of the market in the country.
  
• Moreover, the growing aging population and increasing awareness regarding the advance cardiovascular procedures further solidifying the growth of the market in the country.
  
• For instance, as per the data from Office for National Statistics, the elderly population of the UK is expected to rise significantly. In 2020, an estimated 2.5% of the total population comprised of people aged 85 and over, by 2040 the figure is projected to reach 4.3% of the total population.
  
• Thus, this demographic shift stimulates the need for high quality cardiovascular devices in order to address the age-related heart condition, thereby fostering the market growth in the region.
  

Asia Pacific: Japan cardiovascular devices market is set for lucrative growth from 2024 to 2034.

• The country has a high prevalence of cardiovascular diseases, which in turn propels the demand for advance cardiovascular devices.
  
• For instance, as per the 2023 study published in the Journal of Cardiology, more than 310,000 individuals had lost their lives due to cardiovascular disease in the country.
  
• Therefore, the rising prevalence and morality rate of cardiovascular disease stimulates the demand for advance cardiovascular devices for the effective patient management and treatment.
  

Middle East and Africa: Saudi Arabia cardiovascular devices industry is expected to witness substantial growth during the forecast period.

• The Saudi government's Vision 2030 initiative is focused on enhancing healthcare services and investing in cutting-edge medical technology, particularly for heart health. As a result, more specialized cardiac centers are being established, and advanced diagnostic tools are becoming widely adopted.
  
• At the same time, lifestyle changes have contributed to rising obesity and diabetes rates across Saudi Arabia, increasing the risk of heart disease. This has made cardiovascular care and innovative medical devices more essential than ever in the country.
  

Cardiovascular Devices Market Share

The top 5 players of the market account for approximately 40% of the market share which includes companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, Biotronik, among others. These companies maintain their dominance in the market through innovative product launches, extensive distribution networks and strong regulatory approval. Moreover, strategic partnerships with research organizations, healthcare institutes, and government agencies play a primary role in advancing the development of products. Additionally, the expansion of public awareness through the campaigns on cardiovascular disease prevention and treatment, enabling market players to strengthen their position in this growing sector.

Cardiovascular Devices Market Companies

Some of the eminent market participants operating in the cardiovascular devices industry include:

• Abbott Laboratories
• AngioDynamics
• AtriCure
• Biosense Webster
• Boston Scientific Corporation
• Biotronik
• CardioFocus
• Getinge
• Japan Lifeline
• Karl Storz
• Lepu Medical Technology
• Lifetech Scientific
• Livanova
• Microport Scientific Corporation
• Medical Instruments
• Medtronic
• Occlutech
• Saphena Medical
• Stereotaxis
• Terumo Corporation
  
• Abbott Laboratories has strong global presence, with 70% of revenue is being generated outside the U.S. and around 50% of the revenue is generated from the fast-growing geographies.
  
• Boston Scientific Corporation has a strong product portfolio that addresses the diverse needs of cardiovascular disease management.
  

Cardiovascular Devices Industry News:

• In November 2024, Johnson & Johnson MedTech received FDA approval for its VARIPULSE Pulsed Field Ablation (PFA) Platform, designed for the treatment of drug-refractory paroxysmal atrial fibrillation (AFib). This significant development is based on promising results from the admIRE clinical trial, which demonstrated a remarkable 100% acute procedural success rate among participants.
  
• In October 2024, Boston Scientific launched the next generation of cardiac mapping technology for its FARAPULSE Pulsed Field Ablation (PFA) System. This advancement includes the FARAWAVE NAV Ablation Catheter and the FARAVIEW Software, both of which have received FDA approval and clearance to enhance the treatment of paroxysmal atrial fibrillation (AF).
  

The cardiovascular devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type

• Cardiac ablation devices
  • Radiofrequency ablators
  • Electric ablators
  • Cryoablation devices
  • Ultrasound devices
  • Other cardiac ablation devices
• Left atrial appendage closure devices
  • Endocardial LAA closure devices
  • Epicardial LAA closure devices
• Endoscopic vessel harvesting devices
  • EVH systems
  • Endoscopes
  • Accessories

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Cardiac centers
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE